FLT3 and acute myeloid leukemia: In our study, leukemic cells withdrawn from blood of two AML patients with mutated FLT3 who received induction therapy with daunorubicin and cytarabine showed a prominent increase in FLT3 surface expression already at the first three days of treatment (Fig. 4).